Marketresearchnews

Tuesday, 27 October 2020

Skin Graft Market Value Chain, Factor Analysis, Region And Forecasts Till 2023

Skin Graft Market overview

Skin grafts is a medical procedure that is performed when the injured skin cannot heal itself and in extreme cases it involves the operational procedure that turns out to be quite expensive. Many physicians also use the skin from another donor that makes the procedure more expensive.

Skin grafting is also known as skin harvesting and it includes a surgical procedure in case of burns, skin infections, and other skin problems. The cosmetics sector is also growing the skin grafting market with the changing lifestyle and the latest trends that are affecting the global market in a positive manner.

Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1674

The global skin graft global market report showcases the increased demand for skin grafts because of the increasing cases of burn injuries and skin infections. The rise of advanced technology equipment in skin grafts, attributing to the increased investment in the research and development activity, will positively open new opportunities for the skin grafts market. All these market factors for skin graft will lead to the growth of the global market for $7.5 billion by the end of 2023, moreover the market will be projected to grow at a CAGR of 13.5% for the forecast period from 2017-2023.

Key Players of Global Skin Graft Market:

Key players profiled in the report are

Organogenesis Inc.
Specmed Medical
Stratatech Corp
Tissue Regenix Group PLC
Avita Medical
Convatec Inc
Medrotonic
Coloplast
B.Braun Melsungen
zimmerbiomet
Stratatech Corporation
Zimmer Biomet

Skin Graft Market segmentation

The competitive landscape of the global skin grafts market is segmented owing to the prevalence and presence of various international and national players. On the basis of the skin graft type, the global market can be split into:

Isogeneic
Autologous
Allogeneic
Prosthetic
Xenogeneic

Based on the growth of the global skin graft market can be further segmented based on the graft thickness, such as:

Full-thickness
Split-thickness
Composite graft

And based on the applications, the global market can be classified into:

Burns
Extensive wounds
Extensive skin loss due to infections
Skin cancers
Others

And according to the segmentation done based on the equipment, the global market can classified into:

Dermatome
Consumables
General surgical instruments

And lastly based on end users, the market can be segmented into:

Academic and research
Hospitals and clinics
Others

Skin Graft Market Regional segmentation

The global skin graft market is geographically distributed based on the involvement of various regions for the past few years. The United States accounts for the maximum shares in the skin graft market owing to the favourable reimbursement scenarios and expenditure in the healthcare sector. The introduction of new technologies in the US is also driving the market for global skin graft.

Europe is the second largest market with the rising awareness and the increase in the disposable incomes among the population. The market of China and India is also on its full potential with the gulf nations also participating in the skin graft market.

Skin Graft Industry news

Mallinckrodt has purchased Stratatech Corporation, a regenerative medicine company, for nearly $200 million. The company has announced a merger agreement that is focused on the development of unique, proprietary skin substitute products. These developmental products are using the regenerative skin tissue and a technology platform for genetically enhanced skin tissues.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/skin-graft-market-1674

Europe Dental Software Market Professional Overview 2020-2023 With Major Vendors Size, Shares And Worldwide Demand

Market Scenario:

The Europe Dental Software market is expected to witness high growth in the coming years. The demand for dental software is dignified by improving process quality, patient satisfaction and speeding up the process for the treatments provided by dental organizations, and dental institutes. The growing availability of electronic data offers practitioners increased opportunities for reusing clinical data for research and quality improvement.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3263

Considering the scenario of the Europe Dental Software market, the total market was US$ 488.6 million in 2016 and expected to reach US$ 861.0 million by 2023.

Key Players for Europe Dental Software Market:

Some of the key players in this market are: Carestream Health, Inc (US), Dentsply Sirona (US), Elite Computer Italia (OrisLine Group) (italy), Henry Schein, Inc (US), KaVo Dental GmbH (Germany), PLANMECA OY (Finland)

Segments:

Europe Dental Software Market has been segmented on the basis of type which comprise Practice Management Software, Patient Communication Software, Treatment Planning Software, Patient Education Software, and Dental Imaging Software. Patient management segment was holding largest market share. On the basis of application, it is segmented into Clinical Application, Administrative. Clinical application segment is dominating The European dental software market by application. On the basis of deployment, it is segmented into On-Premise Model, and Web-Based/ Cloud-Based Model. On-premise model is leading in this segment. On the basis of End User it is segmented into Hospitals & Clinics, Academics & Research Institutes. Hospitals and clinics was holding largest market share in 2016.

Regional Analysis of Europe Dental Software Market:

Considering the scenario of Europe Dental Software market, Germany was holding largest Dental software market share of 20.6% in 2016 and is expected to reach 165.9 million by 2023. France is second largest country in Europe Dental Software market. UK is expected to grow at a CAGR of 7.6% during 2017-2023. On the other hand. Eastern Europe Dental Software market is growing significantly and is expected to grow at a CAGR of 7.4% during the forecast period.

The report for Europe Dental Software Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience

Europe Dental Software developers and services providers
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Hospitals and clinics
Dental research centers
Academic institutes and universities
Potential Investors

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-dental-software-industry-3263

MEA HIV Diagnosis & Treatment Market 2020 Synopsis With Leading Players, Industry Growth Factor Foresight By 2023

Market Scenario:

HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV. Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.

Middle East and Africa HIV Aids Diagnosis & Treatment Market is growing moderately. Middle East and Africa HIV Diagnosis & Treatment Market is expected to grow at a CAGR of 3.3% and expected to reach US$ 2.07 billion by 2023 from US$ 1.65 billion in 2016.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2990

Key Players for Middle East and Africa HIV Diagnosis & Treatment Market:

Some of the key players in this market are: Abbott Laboratories (US), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (US), Cipla Inc. (India), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc.(US), ViiV Healthcare group of companies (UK), Merck & Co., Inc. (US).

Segments:

Middle East and Africa HIV Diagnosis & Treatment Market has been segmented on the basis of diagnosis which comprise ELISA Test, Saliva Tests, Viral Load Test, Western Blot, and Others. On the basis of treatment, market is segmented into Protease inhibitors (PIs), Non-nucleoside reverse transcriptase inhibitors (NNRTIs), Nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs), Entry or fusion inhibitors, Integrase inhibitors, and others.

Regional Analysis of Middle East and Africa HIV Diagnosis & Treatment Market:

Considering the scenario of the Middle East and African HIV Diagnosis & Treatment market, Africa is believed to be the largest market for HIV Diagnosis & Treatment. Moreover, the Rest of Middle East and Africa is growing and it is the second largest market for Middle East and Africa HIV Diagnosis & Treatment. On the other hand, UAE market is expected to grow at significant rate in the Middle East and Africa HIV Diagnosis & Treatment during the forecasted period. Saudi Arabia is likely to have a limited but moderate growth in the market.

The report for Middle East and Africa HIV Diagnosis & Treatment Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience

Hospitals and Clinics
HIV Diagnosis & Treatment drugs manufacturers
HIV Diagnosis & Treatment drugs suppliers
Government and Independent Regulatory Authorities
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Medical Research Laboratories
Potential Investors

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hiv-diagnosis-treatment-market-2990

MEA Critical Care Equipment (CCE) Market Likely Boost The Industry Revenue And Demand Till 2023

Market Scenario

Middle East and Africa critical care equipment market is growing moderately. Critical care also known as intensive care is an essential medical practice to cure severe injuries or life-threatening medical conditions. In critical care unit (CCU), medical professionals monitor and treat patient under controlled conditions with the help of critical care equipment. Critical care equipment are very useful to monitor and get accurate information about patient’s health conditions. These equipment provide life support to patients after they have gone through a major surgery, injury or have faced life threatening injuries. Healthcare expenditure is growing in Middle East and Africa region which comprise about 2% of the global healthcare expenditure. Developing healthcare infrastructure, technological advance facilities, government initiatives to improve the healthcare sector and growing cases of non-communicable diseases are driving the growth of the critical care equipment market in Middle East and Africa. This market was about US$ 681.2 million in 2016 and expected to reach US$ 1061.4 million by 2023 growing at the CAGR of 5.7%.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2751

Key Players for Middle East and Africa Critical Care Equipment Market:

Some of the Critical Care Equipment Market Manufacturers are namely Johnson & Johnson Services, Inc. (US), General Electric Company (US), Medtronic (Republic of Ireland), Siemens Healthcare Private Limited (Germany), Baxter (US), Koninklijke Philips N.V. (Netherlands)

Segments:

Middle East and Africa critical care equipment market has been segmented on the basis of type of equipment which includes patient monitor, medical ventilator, dialysis, iv pumps, infusion pump, suction apparatus, and others. On the basis of end user the market is segmented into hospitals, research laboratories and others.

Regional Analysis of Critical Care Equipment Market:

Considering the scenario of Middle East and Africa critical care equipment market, UAE region is believed to be the largest market for the same in the above mentioned region. Moreover, Saudi Arabia market is also growing and is the second largest market for critical care equipment. On the other hand, Egypt’s market is expected to grow at a steady pace in the Middle-East critical care equipment market in future. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

The report of Middle East and Africa critical care equipment market by Market Research Future comprises extensive primary research along with detail analyses of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to estimated terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the market’s segments and regions.

Intended Audience

Hospitals and clinics
Critical care equipment devices manufacturers and suppliers
Government and independent regulatory authorities
Research laboratories
Research and development (R&D) companies
Market research and consulting service providers
Medical research laboratories
Potential investors

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/mea-critical-care-equipment-market-2751

MEA Hypertension Drugs Market Witness A Remarkable Growth Projected By 2022

Market Scenario:

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys. Hypertension affects four out of ten adults in Middle East and Africa region. Over 1.5 million deaths occurs due to hypertension in Middle East and Africa. Countries in Middle East and Africa bear a heavy burden from hypertension diagnosis and treatment. Huge funding in R&D and various initiatives by government are driving the growth for Hypertension Drugs Market in Middle East and Africa. Middle-East and Africa Hypertension Drugs Market is growing moderately. The market is growing at the CAGR of 3.1% and expected to reach to US$ 5.31 billion by 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2636

Segments:

Middle-East and Africa Hypertension Drugs Market classification on the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

Regional Analysis of Middle-East and Africa Hypertension Drugs Market:

Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Key Players for Middle-East and Africa Hypertension Drugs Market:

Some of the key players in this market are: Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc.(UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)

The report for Middle-East and Africa Hypertension Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hypertension-drugs-market-2636

MEA Anti-Fungal Agents Market Strategies And Competitive Analysis, Forecast Till 2022

Market Scenario:

Anti-fungal agents are used in the treatment of fungal infections. According to global action fund for fungal infection, globally, over 300 billion people of all ages suffer from a serious fungal infection every year.

The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2582

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of block buster drugs. Over the counter drugs are an important reasons for the growth of anti-fungal agents market. The Middle East and Africa anti-fungal agents market is led by Azoles followed by Echinocandins. The Azole class is represented in the market by agents such as Noxafil, Vfend, and Diflucan.

Among the infections Dermatophytosis holds the majority share followed by candidiasis. The market leaders with considerable sales include fluconazole, terbinafine, voriconazole, itraconazole, and caspofungin.

Taking all factors into consideration, we expect the Middle East and Africa anti-fungal agents market to reach around $2.85 billion by 2022 from $2.32 billion in 2015, by the end of the forecast period at a CAGR of ~3.5%.

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa anti-fungal drugs market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa anti-fungal agents market
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by product type, by construction material, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Intended Audience

Anti-fungal agents Manufacturers
Anti-fungal agents Suppliers
Private Research Laboratories
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Government Research Laboratories
Contract Manufacturing Organizations

Key Players for Middle East and Africa Anti-fungal agents Market:
Some of the key players in this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.

Segments:

Middle East and Africa anti-fungal agents market has been segmented on the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. On the basis of route of administration; market is segmented into oral, local and others.

Regional Analysis of Middle East and Africa Anti-fungal agents Market:

UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal agents Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.

The report for Middle East and Africa Anti-fungal agents Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/mea-anti-fungal-agents-market-2582

Monday, 26 October 2020

Global Cystic Acne Market Plying for Significant Growth During 2020 - 2023

Market Highlights

Cystic acne is majorly treated with topical medications, drainage & extraction procedure, and laser therapy, and microdermabrasion. Increasing awareness and prevalence of population affected by acne are boosting the demand for a laser treatment that has driven the growth of laser devices and medications for the cystic Acne. The cystic acne market has been a growing market and it has been expected that the market is likely to touch high growth figures.

According to The National Center for Biotechnology Information, in 2015, around 9.4% of the global population is affected by acne and making it the 8th most prevalent disease worldwide. Acne often causes significant physical and psychological problems such as permanent scarring, poor self-image, depression, and anxiety.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1723

The market is expected to flourish in developing regions of Asia Pacific owing to the rising patient population with cystic acne. Increasing prevalence of cystic acne, rising demand for better treatment, increasing investment in the biotechnology and pharmaceutical industries for research and development are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology are expected to fuel the market growth during the forecast period. However, lack of effective treatment in the market may hinder the market growth during the forecast period.

The global cystic acne market is expected to grow at a CAGR of 10% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global cystic acne market owing to the presence of a huge patient population suffering from a skin condition, high health care spending, and increasing government support for research & development. According to American Academy of Dermatology, acne is affecting around 50 million Americans annually and around 20 million American have acne badly enough to cause scars.

Europe holds the second largest share of the global cystic acne market as a result of increasing focus of various government agencies on the treatment of diseases. Moreover, the growing public awareness about cystic acne is likely to boost the European market.

The Asia Pacific is the fastest growing market across the globe. Moreover, rapidly developing the economy, increasing healthcare expenditure, and the government’s initiatives for research & development are projected to drive the market in China and India.

The Middle East and Africa hold the least cystic acne market share of the global market due to limited availability of medical facilities.

Segmentation

The global cystic acne market is segmented on the basis of causes, long-term effects, treatment type and end user. On the basis of the causes, it is segmented into hormonal imbalances, occlusive skin products, drugs/chemical side effects, and others. On the basis of the long-term effects, it is segmented into ice pick scars, larger pits on the skin, shallow depressions, hypertrophic scarring, and others. On the basis of the treatment type, it is segmented into topical medications, drainage & extraction procedure, laser therapy, microdermabrasion, and others. On the basis of the end user, it is segmented into hospitals, clinics, research laboratories, and others.

Key Players

Some of the key players in this market are GlaxoSmithKline plc (U.K), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Hexal AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Alma Lasers Inc. (Israel), Bristol-Myers Squibb Company (U.S.), GE Healthcare (U.K), National Biological Corp. (U.S.), Herbert Waldmann GmbH & Co. KG (Germany), Sylvan Company (U.S.) and DUSA Pharmaceuticals Inc. (U.S.).

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/cystic-acne-market-1723